North American blastomycosis in an immunocompromised patient.

Cutis

Dermatology and Laser Group of Irvine, California, and is affiliated with Hoag Hospital Irvine, California, USA.

Published: December 2019

Blastomycosis is a subacute or chronic deep mycosis caused by a dimorphic fungus, Blastomyces dermatitidis, that generally produces a pulmonary form of the disease and, to a lesser extent, extrapulmonary forms, such as cutaneous, osteoarticular, and genitourinary. Both immunocompetent and immunocompromised individuals can be infected, but more severe disease occurs in the immunocompromised. Blastomycosis can be diagnosed by culture, direct visualization of the yeast in affected tissue, antigen testing, or a combination of these methods. Treatment course and duration depend on the severity of illness. For mild to moderate pulmonary disease, treatment is itraconazole. For severe blastomycosis, lipid-formulation amphotericin B is given, followed by itraconazole. We present an interesting case of cutaneous blastomycosis acquired in Atlanta, Georgia, that looks quite similar to other mycoses, such as coccidioidomycosis and sporotrichosis, and describe its distinguishing features.

Download full-text PDF

Source

Publication Analysis

Top Keywords

blastomycosis
5
north american
4
american blastomycosis
4
blastomycosis immunocompromised
4
immunocompromised patient
4
patient blastomycosis
4
blastomycosis subacute
4
subacute chronic
4
chronic deep
4
deep mycosis
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!